Content about Glimepiride

December 15, 2011

A study conducted by Bristol-Myers Squibb and AstraZeneca found that adding an investigational compound to an existing Type 2 diabetes treatment may help reduce blood-glucose levels among patients.

DUBAI — A study conducted by Bristol-Myers Squibb and AstraZeneca found that adding an investigational compound to an existing Type 2 diabetes treatment may help reduce blood-glucose levels among patients.

December 8, 2011

A drug currently under clinical development for Type 2 diabetes produced "meaningful" reductions in blood sugar, according to results of a late-stage clinical study.

INDIANAPOLIS — A drug currently under clinical development for Type 2 diabetes produced "meaningful" reductions in blood sugar, according to results of a late-stage clinical study.

Eli Lilly & Co. and Boehringer Ingelheim announced results of a 24-week, open-label arm of a phase-3 study of the investigational drug linagliptin combined with the generic drug metformin, presenting results at the International Diabetes Federation World Diabetes Conference in Dubai.

November 4, 2011

Marsh Supermarkets is offering a new program for patients with diabetes, according to the Indianapolis-based chain's website.

INDIANAPOLIS — Marsh Supermarkets is offering a new program for patients with diabetes, according to the Indianapolis-based chain's website.

Under Marsh's Diabetes Care program, patients who bring a new prescription to a Marsh supermarket pharmacy or transfer an existing one will receive up to a 30-day supply of qualifying generic diabetes medications for free, as well as free universal lancets.

The medications include glipizide, metformin, glimepiride and glyburide. The program is available through the end of May 2012.

May 19, 2011

A controversial GlaxoSmithKline drug for treating Type 2 diabetes no longer will be available through retail pharmacies as of Nov. 18, the Food and Drug Administration announced Wednesday.

SILVER SPRING, Md. — A controversial GlaxoSmithKline drug for treating Type 2 diabetes no longer will be available through retail pharmacies as of Nov. 18, the Food and Drug Administration announced Wednesday.